Dry Eye Treatment Eye Drops Franchise in Ahmedabad

Ciclosporin Eye Drops Supplier in Mumbai

Ocular Surface Disease Care Distributor in Delhi

Dry Eye Pharma Franchise in Bangalore

Ciclosporin 0.1% Eye Drops Stockist in Hyderabad
Ophthalmic Dry Eye Care Eye Drop Manufacturer & Exporter in Chandigarh

Home/Products /ciclosporin-0-1-w-v-eye-drop

Ciclomax Eye Drops

Composition : Ciclosporin (0.1% w/v) Eye drops

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 10ml

Price : ₹0/-

Ciclomax Eye Drops contain Ciclosporin 0.1% w/v, an advanced ophthalmic immunomodulator formulated for the long-term management of moderate to severe dry eye disease and ocular surface inflammation. Its higher-strength formulation supports enhanced tear production and sustained symptom relief.

Ciclosporin works by suppressing T-cell–mediated inflammation on the ocular surface, helping to restore tear film stability, reduce irritation, and improve overall ocular comfort with continued use.

From a commercial perspective, Ciclomax Eye Drops address a rapidly expanding dry eye treatment market, making them a high-value, repeat-prescription product for ophthalmologists and eye care specialists.

Including Ciclomax Eye Drops in your portfolio strengthens the dry eye and ocular surface disease segment, delivering long-term business stability, strong prescriber loyalty, and premium brand positioning for PCD pharma franchise partners.

Read More

About the Product

Ciclomax Eye Drops contain Ciclosporin 0.1% w/v, an advanced ophthalmic immunomodulator formulated for the long-term management of moderate to severe dry eye disease and ocular surface inflammation. Its higher-strength formulation supports enhanced tear production and sustained symptom relief.

Ciclosporin works by suppressing T-cell–mediated inflammation on the ocular surface, helping to restore tear film stability, reduce irritation, and improve overall ocular comfort with continued use.

From a commercial perspective, Ciclomax Eye Drops address a rapidly expanding dry eye treatment market, making them a high-value, repeat-prescription product for ophthalmologists and eye care specialists.

Including Ciclomax Eye Drops in your portfolio strengthens the dry eye and ocular surface disease segment, delivering long-term business stability, strong prescriber loyalty, and premium brand positioning for PCD pharma franchise partners.

Common side effects may include burning or stinging sensation on instillation, eye redness, irritation, watery eyes, or blurred vision. Rarely, hypersensitivity reactions may occur.

Ciclomax Eye Drops are indicated for the treatment of moderate to severe chronic dry eye disease (keratoconjunctivitis sicca) associated with ocular surface inflammation. It is suitable for long-term management under ophthalmologist supervision.

Use Ciclomax Eye Drops strictly as prescribed by an ophthalmologist. Avoid touching the dropper tip to the eye to prevent contamination. Regular and consistent use is essential for optimal benefit, and symptomatic improvement may take several weeks. Discontinue use and consult a doctor if severe irritation or allergic reactions occur.

Store in a cool, dry place below 25 °C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use after the expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation